Table 4 Comparison of the effectiveness of oseltamivir and zanamivir against the oseltamivir-susceptible and oseltamivir-resistant influenza A(H1N1) infections
| Â | Oseltamivir-treated cases | Â | Zanamivir-treated cases | Â | ||
|---|---|---|---|---|---|---|
| Â | 2007-2008 Oseltamivir-susceptible (n = 8) | 2008-2009 Oseltamivir-resistant (n = 25) | P-value | 2007-2008 Oseltamivir-susceptible (n = 4) | 2008-2009 Oseltamivir-resistant (n = 6) | P-value |
Age, years; median (range) | 6 (1-9) | 5 (2-9) | .8155 | 8 (7-11) | 11 (9-12) | .0506 |
Maximum body temperature, °C; median (range) | 39.3 (38.9-39.8) | 39.1 (38.2-40.6) | .3874 | 39.2 (38.6-39.6) | 39.0 (38.2-39.6) | .5906 |
Total febrile period, days; median (range) | 3.5 (2-5) | 4 (2-7) | .0503 | 3 (2-4) | 3 (3-4) | .4642 |
Duration of fever after the start of therapy, days; median (range) | 1.5 (1-2) | 2 (1-6) | .0356 | 1 (1-2) | 1 (1-3) | .6926 |